Comparative Effectiveness of All Available Treatments for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-analysis
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- 2020
has subject area
- 1117 Public Health and Health Services (FoR)
- Androgen Antagonists (MeSH)
- Androstenes (MeSH)
- Antineoplastic Agents, Hormonal (MeSH)
- Antineoplastic Combined Chemotherapy Protocols (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Docetaxel (MeSH)
- Drug Resistance, Neoplasm (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Network Meta-Analysis (MeSH)
- Progression-Free Survival (MeSH)
- Prostatic Neoplasms (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Survival Rate (MeSH)
- Systematic Reviews as Topic (MeSH)
published in
- American Journal of Therapeutics Journal